Publication

2016

Visconte V, Nawrocki ST, Espitia CM, Kelly KR, Possemato A, Beausoleil SA, Han Y, Carraway HE, Nazha A, Advani AS, et al. 2016. Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidine. Leukemia. 30:1190–4. doi:10.1038/leu.2015.250.
Keenen MM and Kim S. (2016) Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells. Breast Cancer (Dove Med Press) 8:211-221. PMID: 27895513 Kim S. (2015) New and emerging factors in tumorigenesis: an overview. Cancer Manag Res . 2016.